HIGHLIGHTS
- who: Retraction from the (UNIVERSITY) have published the article: Retraction Retracted: Efficacy and Safety of Temozolomide Combined with Radiotherapy in the Treatment of Malignant Glioma, in the Journal: Journal of Healthcare Engineering of 14/Nov/2022
SUMMARY
Received Published @@
ACRONYMS
LAY DEFINITIONS
- Temozolomide: A dacarbazine derivative that is used as an alkylating antineoplastic agent for the treatment of MALIGNANT GLIOMA and MALIGNANT MELANOMA.
- Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.